Cargando…
Inability to contact opioid agonist therapy prescribers during the COVID-19 pandemic in a Canadian setting: a cross-sectional analysis among people on opioid agonist therapy
BACKGROUND: The COVID-19 pandemic and consequent public health response may have undermined key responses to the protracted drug poisoning crisis, including reduced access to opioid agonist therapy (OAT) among people with opioid use disorder. Our study objectives were to estimate the prevalence of a...
Autores principales: | Moallef, Soroush, DeBeck, Kora, Fairbairn, Nadia, Cui, Zishan, Brar, Rupinder, Wilson, Dean, Johnson, Cheyenne, Milloy, M.-J., Hayashi, Kanna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9751503/ https://www.ncbi.nlm.nih.gov/pubmed/36522789 http://dx.doi.org/10.1186/s13722-022-00354-x |
Ejemplares similares
-
The relationship between opioid agonist therapy satisfaction and fentanyl exposure in a Canadian setting
por: Mackay, Lindsay, et al.
Publicado: (2021) -
A drug-related Good Samaritan Law and calling emergency medical services for drug overdoses in a Canadian setting
por: Moallef, Soroush, et al.
Publicado: (2021) -
The influence of poly-drug use patterns on the association between opioid agonist treatment engagement and injecting initiation assistance
por: Meyers-Pantele, Stephanie A., et al.
Publicado: (2022) -
Impacts of the COVID-19 pandemic on enrollment in medications for opioid use disorder (MOUD) in Vancouver, Canada: An interrupted time series analysis
por: Eugenia Socias, M., et al.
Publicado: (2023) -
Low awareness of risk mitigation prescribing in response to dual crises of COVID-19 and overdose deaths among people who use unregulated drugs in Vancouver, Canada
por: Moshkforoush, Mana, et al.
Publicado: (2022)